Masoprocol
From Wikipedia, the free encyclopedia
Masoprocol
|
|
Systematic (IUPAC) name | |
4-[4-(3,4-dihydroxyphenyl)- 2,3-dimethyl-butyl]benzene-1,2-diol | |
Identifiers | |
CAS number | |
ATC code | L01 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C18H22O4 |
Mol. mass | 302.365 g/mol |
Pharmacokinetic data | |
Bioavailability | Very low |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
B(US) |
Legal status | |
Routes | Topical |
Masoprocol is an antineoplastic drug used to treat skin growths caused by sun exposure. A form of nordihydroguaiaretic acid that is taken by mouth is being studied in the treatment of prostate cancer. Nordihydroguaiaretic acid is an antioxidant, and it may block certain enzymes needed for tumor growth. Also called nordihydroguaiaretic acid, NDGA, and actinex.
[edit] References
- MedlinePlus Drug Information
- Actinex entry in the public domain NCI Cancer Dictionary